Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 1, 2012, Pages 149-157

  Hsu, Priscilla C ^a,b   Federico, Carole A ^a,b   Krajden, Mel ^a,b   Yoshida, Eric M ^b   Bremner, Karen E ^d   Anderson, Frank H ^c   Weiss, Alan A ^b   Krahn, Murray D ^d,e  

^a BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Liver and Intestinal Research Centre   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cirrhosis; Hepatitis C virus; Quality of life; Sustained virologic response; Utility

Indexed keywords

ADULT; AGING; ARTICLE; CANADA; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; HEALTH CARE UTILIZATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; TERTIARY HEALTH CARE; VIRAL CLEARANCE;

EID: 84155174944     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06813.x     Document Type: Article

References (47)

1. World Health Organization. Viral Cancers: Hepatitis C Virus [Internet]. Geneva: World Health Organization. 2010. Available from URL:.
2. World Health Organization. Global Alert and Response, Hepatitis C. Surveillance and Control [Internet]. Geneva: World Health Organization. 2002. Available from URL:.
3. Khalili M, Vardanian AJ, Hamerski CM etal. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin. Transplant. 2006; 20: 1-9.
4. Teo M, Hayes P. Management of hepatitis C. Br. Med. Bull. 2004; 70: 51-69.
5. Chong CA, Gulamhussein A, Heathcote EJ etal. Health-state utilities and quality of life in hepatitis C patients. Am. J. Gastroenterol. 2003; 98: 630-8.
6. John-Baptiste AA, Tomlinson G, Hsu PC etal. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C. Am. J. Gastroenterol. 2009; 104: 2439-48.
7. Morgan TR, Ghany MG, Kim HY etal. Outcome of sustained virologic responders with histologically advanced chronic hepatitis C. Hepatology 2010; 52: 833-44.
8. Fryback DG, Dasbach EJ, Klein R etal. The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med. Decis. Making 1993; 13: 89-102.
9. Luo N, Johnson JA, Shaw JW etal. Self-reported health status of the general adult U.S. population as assessed by the EQ-5D and Health Utilities Index. Med. Care 2005; 43: 1078-86.
10. Fryback DG, Dunham NC, Palta M etal. US norms for six generic health-related quality-of-life indexes from the National Health Measurement study. Med. Care 2007; 45: 1162-70.
11. Gutteling JJ, de Man RA, van der Plas SM etal. Determinants of quality of life in chronic liver patients. Aliment. Pharmacol. Ther. 2006; 23: 1629-35.
12. Fontana RJ, Moyer CA, Sonnad S etal. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am. J. Gastroenterol. 2001; 96: 170-8.
13. Younossi ZM, Boparai N, McCormick M etal. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am. J. Gastroenterol. 2001; 96: 579-83.
14. Hsu PC, Krajden M, Yoshida EM etal. Does cirrhosis affect quality of life in hepatitis C virus-infected patients? Liver Int. 2009; 29: 449-58.
15. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol. Behav Neurol. 1998; 1: 111-17.
16. Barber M, Stott DJ. Validity of the Telephone Interview for Cognitive Status (TICS) in post-stroke subjects. Int. J. Geriatr. Psychiatry 2004; 19: 75-9.
17. Debling D, Amelang M, Hasselbach P etal. Assessment of cognitive status in the elderly using telephone interviews. Z Gerontol. Geriatr. 2005; 38: 360-7.
18. Bayliss MS, Gandek B, Bungay KM etal. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual. Life Res. 1998; 7: 39-55.
19. Gutteling JJ, de Man RA, Busschbach JJ etal. Overview of research on health-related quality of life in patients with chronic liver disease. Neth. J. Med. 2007; 65: 227-34.
20. Saris-Baglama RN, Dewey CJ, Chisholm GB etal. SF Health Outcomes Scoring Software User's Guide. Lincoln, RI: QualityMetric Incorporated, 2004.
21. Furlong WJ, Feeny DH, Torrance GW etal. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann. Med. 2001; 33: 375-84.
22. Torrance GW, Furlong W, Feeny D etal. Multi-attribute preference functions. Health Utilities Index. Pharmacoeconomics 1995; 7: 503-20.
23. Torrance GW. Utility approach to measuring health-related quality of life. J. Chronic Dis. 1987; 40: 593-603.
24. Sherman KE, Sherman SN, Chenier T etal. Health values of patients with chronic hepatitis C infection. Arch. Intern. Med. 2004; 164: 2377-82.
25. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J. Health Econ. 2002; 21: 271-92.
26. Charlson ME, Pompei P, Ales KL etal. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987; 40: 373-83.
27. Greenfield S, Apolone G, McNeil BJ etal. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med. Care 1993; 31: 141-54.
28. Stewart AL, Greenfield S, Hays RD etal. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989; 262: 907-13. Erratum in: JAMA. 1989;262(18):2542.
29. Samsa G, Edelman D, Rothman ML etal. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15: 141-55.
30. Horsman J, Furlong W, Feeny D etal. The Health Utilities Index (HUI): concepts, measurement properties and applications. Health Qual. Life Outcomes 2003; 1: 54.
31. Walters SJ, Brazier JE. What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D. Health Qual. Life Outcomes 2003; 1: 4.
32. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med. Care 2003; 41: 582-92.
33. Judd CM, McClelland GH. Data Analysis: A Model Comparison Approach. New York: Harcourt Brace Jovanovich, 1989; 204.
34. Henderson HV, Velleman PF. Building multiple regression models interactively. Biometrics 1981; 37: 391-411.
35. Mittmann N, Trakas K, Riseborough N etal. Utility scores for chronic conditions in a community-dwelling population. Pharmacoeconomics 1999; 15: 369-76.
36. Ware JE Jr, Bayliss MS, Mannocchia M etal. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999; 30: 550-5.
37. Barrett S, Goh J, Coughlan B etal. The natural course of hepatitis C virus infection after 22years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001; 49: 423-30.
38. McHutchison JG, Ware JE Jr, Bayliss MS etal. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J. Hepatol. 2001; 34: 140-7.
39. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29: 264-70.
40. Bernstein D, Kleinman L, Barker CM etal. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002; 35: 704-8.
41. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin. Liver Dis. 1999; 19: 329-38.
42. Llovet JM, Fuster J, Bruix J etal. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004; 10 (Suppl. 1): S115-20.
43. Younossi ZM, Boparai N, Price LL etal. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am. J. Gastroenterol. 2001; 96: 2199-205.
44. Helbling B, Overbeck K, Gonvers JJ etal. Host- rather than virus-related factors reduce health-related quality of life in hepatitis C virus infection. Gut 2008; 57: 1597-603.
45. Gjeruldsen S, Loge JH, Myrvang B etal. Drug addiction in hepatitis C patients leads to a lower quality of life. Nord. J. Psychiatry 2006; 60: 157-61.
46. Levy AR, Kowdley KV, Iloeje U etal. The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Value Health 2008; 11: 527-38.
47. Chong CAKY, Li S, Nguyen GC etal. Health-state utilities in a prisoner population: a cross-sectional survey. Health Qual. Life Outcomes 2009; 7: 78.